Physician profile
Deepa Reddy
NPI 1316986086
$735.57
in general payments reported to CMS, 2019-2025
15 companies · $18.67 in 2025
The $18.67 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $167 · 2021: $34.39 · 2022: $112 · 2023: $111 · 2025: $18.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $129.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $178.25 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $155.05 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $97.03 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $65.26 | 2022-2023 | Rebyota |
| Intercept Pharmaceuticals, INC. | $40.82 | 2023 | Ocaliva |
| Gilead Sciences, INC. | $36.81 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $30.76 | 2020-2023 | Dificid |
| Allergan, INC. | $25.25 | 2020 | |
| Dynavax Technologies Corporation | $22.14 | 2020 | |
| Abbott Laboratories | $17.55 | 2021 | |
| Pfizer INC. | $15.01 | 2020 | |
| Redhill Biopharma INC. | $14.90 | 2020 | |
| Olympus America INC. | $13.21 | 2020 | |
| Braintree Laboratories, INC. | $12.70 | 2019 | |
| Daiichi Sankyo INC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepa Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.